user

4-Ipomeanol (4-IM) toxicity through induction of cytochrome CYP4B1 under an EGR1 promoter

被引：0
|
作者：
Hsu, H
Rainov, NG
Sun, F
Sakamoto, KM
Spear, MA
机构：
[1] Univ Calif San Diego, Ctr Canc, Translat Canc Res Program, Gene Therapy Program, San Diego, CA 92103 USA
[2] Univ Halle Wittenberg, Dept Neurosurg, Mol Neurooncol Lab, Halle, Germany
[3] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Dept Pediat, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Dept Pathol, Los Angeles, CA USA
来源：
CANCER GENE THERAPY | 1999年 / 6卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
PD87
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [21] Synthesis and evaluation of fluorine-18 labeled ipomeanol as a CYP4B1 expression imaging probe
    Moon, Byung Seok
    Jang, Su Jin
    Lee, Tae Sup
    Lee, Byung Chul
    Kang, Joo Hyun
    Kim, Sang Eun
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [22] CYP4B1 AS A NOVEL SUICIDE GENE IN CANCER THERAPY
    Hanenberg, Helmut
    Roellecke, Katharina
    Wiek, Constanze
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S8 - S9
  • [23] A transgenic mouse expressing human CYP4B1 in the liver
    Imaoka, S
    Hayashi, K
    Hiroi, T
    Yabusaki, Y
    Kamataki, T
    Funae, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (03) : 757 - 762
  • [24] The Effect of Cytochrome P450 Family 4 Subfamily B Member 1 (CYP4B1) on Lung Adenocarcinoma (LUAD) Immune Microenvironment
    Al-Kraimeen, L.
    Ababneh, O.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S558 - S558
  • [25] New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol
    Rainov, NG
    Dobberstein, KU
    Sena-Esteves, M
    Herrlinger, U
    Kramm, CM
    Philpot, RM
    Hilton, J
    Chiocca, EA
    Breakefield, XO
    HUMAN GENE THERAPY, 1998, 9 (09) : 1261 - 1273
  • [26] Lung-selective regulation of CYP2F1 and CYP4B1
    Yost, GS
    DRUG METABOLISM REVIEWS, 2002, 34 : 24 - 24
  • [27] CYTOTOXICITY OF 4-IPOMEANOL (4-IPO) IN C3H/10T1/2 CELLS EXPRESSING PULMONARY CYTOCHROME-P-450 4B1
    SMITH, PB
    TIANO, HF
    PHILPOT, RM
    NESNOW, S
    LANGENBACH, RJ
    FASEB JOURNAL, 1994, 8 (07): : A1249 - A1249
  • [28] CYP4B1:: Expression in urothelial cells, polymorphism and bladder cancer
    Roos, PH
    Dörrenhaus, A
    Roth, G
    Seidel, T
    Dietrich, H
    Golka, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 131 - 131
  • [29] Active site characteristics of CYP4B1 probed with aromatic ligands
    Henne, KR
    Fisher, MB
    Iyer, KR
    Lang, DH
    Trager, WF
    Rettie, AE
    BIOCHEMISTRY, 2001, 40 (29) : 8597 - 8605
  • [30] CYP4B1 is a possible risk factor for bladder cancer in humans
    Imaoka, S
    Yoneda, Y
    Sugimoto, T
    Hiroi, T
    Yamamoto, K
    Nakatani, T
    Funae, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 277 (03) : 776 - 780
12345